Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.02168-20Source: DataRank Database

Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate is a research paper published in Antimicrobial Agents and Chemotherapy (2020). On theSindex it has a DataRank of 0.761. It has been cited 20 times, with 13 citing works in its 1-hop citation network.

N/A

0.761DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access20 citations · 13 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT00042289

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)OA: bronzeTopics (36)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 60%Citation Network 40%

Base Score Contribution

0.457

From this paper's citation signal

Citation Network Contribution

0.304

From 11 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 13 citers.

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
CPT Pharmacometrics & Systems Pharmacology202312 citations32 referencesContributes 0.080
Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases
CPT Pharmacometrics & Systems Pharmacology20244 citations21 referencesContributes 0.077
Physiologically-Based Pharmacokinetic Modeling of Tenofovir Disoproxil Fumaratein Pregnant Women
Current Drug Metabolism20227 citations42 referencesContributes 0.050
Population Pharmacokinetics of Tenofovir Alafenamide Fumarate and Its Metabolite Tenofovir in Healthy Chinese Volunteers
Clinical Pharmacology in Drug Development20233 citations35 referencesContributes 0.040
Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy
Frontiers in Reproductive Health20234 citations55 referencesContributes 0.029

Authors (8)

Kensuke Shoji ORCID,Brookie M. Best ORCID,Jeremiah D. Momper ORCID,Alice Stek,Tim R. Cressey ORCID

Live enrichment

PubMed:33318014 PMC:PMC8092509

NIAID NIH HHS

Grant: P30 AI094189

NICHD NIH HHS

Grant: HHSN275201800001C

NICHD NIH HHS

Grant: K23 HD104517

NIAID NIH HHS

Grant: UM1 AI068632

NCATS NIH HHS

Grant: UL1 TR000124

NIAID NIH HHS

Grant: UM1 AI069536

NIAID NIH HHS

Grant: UM1 AI106716

NIAID NIH HHS

Grant: UM1 AI068634

NICHD NIH HHS

Grant: HHSN275201800001I

NCATS NIH HHS

Grant: UL1 TR000154

NIAID NIH HHS

Grant: UM1 AI068616

NCATS NIH HHS

Grant: UL1 TR000423

NCATS NIH HHS

Grant: UL1 TR001881

National Institutes of Health

Grant: 3UL1TR000423-07S1

Institute of Translational Health Sciences

National Institutes of Health

Grant: 5UM1AI106716-07

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center

National Institutes of Health

Grant: 5UM1AI068616-14

SDMC - IMPAACT Leadership Group

National Institutes of Health

Grant: 3UL1TR000154-05S1

Colorado Clinical and Translational Science Institute (UL1)

National Institutes of Health

Grant: 5UL1TR000124-04

UCLA Clinical and Translational Science Institute

National Institutes of Health

Grant: 7UM1AI068632-07

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group

bronzeLicense: ASM Journals Non-Commercial TDM

https://doi.org/10.1128/aac.02168-20

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092509

https://pubmed.ncbi.nlm.nih.gov/33318014

https://dx.doi.org/10.1128/aac.02168-20

https://escholarship.org/uc/item/41n552r7

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

HumansHIV-1HIV InfectionsAnti-HIV AgentsPostpartum PeriodPregnancyFemaleTenofovir

Keywords

PregnancyAIDSHIVPostpartumTenofovir Disoproxil FumarateTenofovirPopulation PharmacokineticsTdfAnti-HIV AgentsMaternal Health610HIV InfectionsReproductive health and childbirthMicrobiologyClinical Research616HumansBiomedical and Clinical SciencesPostpartum PeriodPharmacology and Pharmaceutical SciencesMedical microbiologyReproductive MedicineHIV-1Women's HealthFemale

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (1)

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial

N/A

1.7DataRank · unranked

EClinicalMedicine(2021)

co-cited

10.1016/j.eclinm.2021.100893

Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (8)

Funding (19 grants)

Open Access

Topics

Annotations (Europe PMC)

Related Papers (1)